Table 1 of Abu-Amero, Mol Vis 2009; 15:1594-1598.


Table 1. Clinical characteristics of POAG patients.


Patient

Age

Sex

Race
VA
OD
VA
OS
Max IOP
OD
Max IOP
OS
Vertical C/D
OD
Vertical C/D
OS
HVF PSD
OD
HVF PSD
OS
1 54 M C 20/100 20/20 54 34 0.9 0.3 12.94 1.53
2 63 F C 20/40 20/25 29 30 0.4 0.7 1.36 11.97
3 62 M C 20/16 20/16 30 29 0.8 0.8 5.78 11.36
4 81 M C 20/25 20/25 25 24 0.85 0.85 10.37 1.83
5 71 F C 20/100 20/25 27 27 0.9 0.9 7.38 12.33
6 60 F C 20/30 CF 35 26 0.9 0.9 12.37 5.37
7 79 M C 20/20 20/20 28 21 0.85 0.65 2.18 1.89
8 97 M C HM 20/25 40 27 0.99 0.99 1.86 11.38
9 90 F C 20/70 20/30 20 20 0.9 0.8 8.83 8.84
10 63 M AA 20/25 20/20 25 25 0.8 0.85 1.46 3.8
11 64 F C 20/30 20/20 23 21 0.9 0.9 11.78 10.49
12 66 M AA 20/20 20/25 32 30 0.9 0.9 10.03 8.28
13 68 F AA 20/20 20/25 30 30 0.5 0.6 1.27 1.99
14 75 F C 20/400 20/30 25 25 0.95 0.8 10.63 3.73
15 81 F C 20/70 20/25 30 20 0.8 0.65 4.62 1.91
16 76 M AA 20/30 20/30 26 26 0.3 0.7 1.7 3.4
17 65 M AA 20/30 20/50 29 31 0.85 0.8 1.81 1.98
18 84 M C 20/20 20/20 31 34 0.5 0.5 3.75 4.02
19 57 M AA 20/70 20/50 41 42 0.9 0.9 13.66 8.9
20 65 M AA 20/200 CF 38 38 0.95 0.95 12.88 3.56
21 62 M AA 20/20 20/20 27 27 0.8 0.8 9.31 9.43
22 56 F AA 20/200 20/40 30 23 0.9 0.3 4.81 1.77
23 69 M AA 20/25 20/25 16 18 0.7 0.8 12.38 7.67
24 86 F AA 20/20 20/40 29 29 0.3 0.3 4.09 6.51
25 73 F C 20/25 20/100 22 23 0.8 0.8 14.88 14.3
26 72 M AA 20/25 20/25 24 28 0.2 0.8 3.29 11.76
27 69 F AA 20/20 20/25 15 14 0.95 0.95 10.54 11.31